搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
3 天
Protagonist Reports Final Results From Rusfertide Phase 2 REVIVE Study Showing Durable ...
54% of patients experience more than 2.5 years of durable hematocrit (Hct) control (<45%), decreased phlebotomy use, long-term tolerability, and improvements in patient-reported outcomes in patients ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
今日热点
Commuting 1,500 sentences
FBI director resigning
Reveals cancer diagnosis
Biden's nominee rejected
NZ reverses visa refusal
Meta donates $1M to Trump
Two US states sue Glock
Vows to 'fight to the end'
Plane crashes into cars
Franklin Fire rages
Storm slams East Coast
Wholesale inflation surged
On Iran 'mothership' claim
Time's Person of the Year
Youngest ever chess champ
House passes JUDGES Act
Undergoes 2nd procedure
US citizen found in Syria
Urges global debt relief
Granola bars recalled
TPG co-founder dies at 82
US asks court to reject bid
NC Helene veto overridden
Net worth tops $400B
Texas sues chemical giants
Jobless claims rise to 242K
Invites Xi to inauguration
FAA administrator to resign
Overdraft fees crackdown
Ex-informant to plead guilty
Stanley recalls 2.6M mugs
To restructure its business
Louisville police reform deal
Combs faces 3 new suits
反馈